Achieve Life Sciences Management
Management criteria checks 1/4
Achieve Life Sciences' CEO is Rick Stewart, appointed in Aug 2024, has a tenure of less than a year. total yearly compensation is $1.35M, comprised of 33.3% salary and 66.7% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth $229.53K. The average tenure of the management team and the board of directors is 0.8 years and 2.7 years respectively.
Key information
Rick Stewart
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 33.3% |
| CEO tenure | less than a year |
| CEO ownership | 0.1% |
| Management average tenure | less than a year |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement
Jul 01Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?
Jan 27
Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?
Oct 26Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?
Mar 26Achieve Life Sciences begins phase 2 trial testing cytisinicline for nicotine e-cigarette cessation
Jun 29Achieve Life Sciences: Initiating Buy, Potential Multi-Billion-Dollar Smoking Cessation Drug
Apr 04Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?
Mar 22Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?
Sep 27We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully
Jun 14We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate
Mar 01Achieve Life Sciences prices stock offering at $7; shares down 2%
Dec 03Achieve Life Sciences launches equity offering
Nov 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$33m |
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$27m |
| Dec 31 2023 | US$1m | US$450k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$42m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$1m | US$400k | -US$42m |
| Sep 30 2022 | n/a | n/a | -US$38m |
| Jun 30 2022 | n/a | n/a | -US$32m |
| Mar 31 2022 | n/a | n/a | -US$33m |
| Dec 31 2021 | US$1m | US$400k | -US$33m |
| Sep 30 2021 | n/a | n/a | -US$31m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$19m |
| Dec 31 2020 | US$1m | US$474k | -US$15m |
| Sep 30 2020 | n/a | n/a | -US$13m |
| Jun 30 2020 | n/a | n/a | -US$13m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$797k | US$500k | -US$16m |
| Sep 30 2019 | n/a | n/a | -US$17m |
| Jun 30 2019 | n/a | n/a | -US$16m |
| Mar 31 2019 | n/a | n/a | -US$16m |
| Dec 31 2018 | US$1m | US$500k | -US$13m |
| Sep 30 2018 | n/a | n/a | -US$13m |
| Jun 30 2018 | n/a | n/a | -US$16m |
| Mar 31 2018 | n/a | n/a | -US$13m |
| Dec 31 2017 | US$500k | US$208k | -US$11m |
Compensation vs Market: Rick's total compensation ($USD1.35M) is about average for companies of similar size in the US market ($USD1.46M).
Compensation vs Earnings: Rick's compensation has increased whilst the company is unprofitable.
CEO
Rick Stewart (65 yo)
less than a year
Tenure
US$1,350,905
Compensation
Dr. Richard A. B. Stewart, also known as Rick, had been an Executive Chairman at Achieve Life Sciences, Inc. since September 28, 2020 until August 2024 and serves as its Chief Executive Officer from August...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.7yrs | US$281.35k | 0% $ 0 | |
| CEO & Executive Director | less than a year | US$1.35m | 0.15% $ 229.5k | |
| President | 4.2yrs | US$1.20m | 0.097% $ 148.8k | |
| Principal Accounting Officer | no data | no data | 0.037% $ 56.7k | |
| Chief Scientific Officer | 7.3yrs | US$589.66k | no data | |
| Chief Commercial Officer | 7.8yrs | no data | 0.076% $ 117.8k | |
| Head of Medical Affairs | less than a year | no data | no data | |
| Executive Vice President of CMC & Regulatory CMC | less than a year | no data | no data |
0.8yrs
Average Tenure
66yo
Average Age
Experienced Management: ACHV's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.7yrs | US$281.35k | 0% $ 0 | |
| CEO & Executive Director | 7.8yrs | US$1.35m | 0.15% $ 229.5k | |
| President | 3.7yrs | US$1.20m | 0.097% $ 148.8k | |
| Independent Director | 2.7yrs | US$195.82k | 0% $ 0 | |
| Independent Director | 1.7yrs | US$270.60k | 0% $ 0 | |
| Independent Director | 1.7yrs | US$269.75k | 0% $ 0 | |
| Independent Director | 3.7yrs | US$198.75k | 0% $ 0 |
2.7yrs
Average Tenure
63yo
Average Age
Experienced Board: ACHV's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.